| 序号 | 产品名称 | 产品数量 |
| 1 | 4-Methoxyamphetamine(hydrochloride)(exempt preparation) | 1 |
| 2 | 3706-26-1 | 1 |
| 3 | 7-hydroxy Mitragynine | 1 |
| 4 | 174418-82-7 | 1 |
| 5 | DLAC | 1 |
| 6 | 70803-56-4 | 1 |
| 7 | β-Amyloid 1-16(Amyloidβ-Protein(1-16)) | 1 |
| 8 | Nezukone(C2-deoxyhinokitiol) | 1 |
| 9 | 4-(Aminomethyl)benzoic acid(α-Amino-p-toluic acid) | 1 |
| 10 | Fludrocortisone acetate(9α-Fludrocortisone acetate) | 1 |
| 11 | Oxythiamine diphosphate | 1 |
| 12 | 10497-04-8 | 1 |
| 13 | (±)-Maackiain dl-Maackiain | 1 |
| 14 | (±)-LY 395756 | 1 |
| 15 | MLCK inhibitor peptide | 1 |
| 16 | 198694-74-5 | 1 |
| 17 | (±)-HIP-B | 1 |
| 18 | (±)-Decanoylcarnitine chloride | 1 |
| 19 | (6-)&epsilon-?Aminocaproic acid | 1 |
| 20 | CAY10700 | 1 |
| 21 | 5(S)-HETE MaxSpec? Standard | 1 |
| 22 | 1-(3-Methoxyphenyl)piperazine | 1 |
| 23 | 25I-NBOH(hydrochloride) | 1 |
| 24 | 1539266-12-0 | 1 |
| 25 | 3-Hydroxyisobutyrate(sodium salt) | 1 |
| 26 | 4'-chloro-α-Pyrrolidinovalerophenone(hydrochloride) | 1 |
| 27 | 5537-17-7 | 1 |
| 28 | JWH 018 5-hydroxyindole metabolite | 1 |
| 29 | 1307803-43-5 | 1 |
| 30 | Quadrol(N,N,N',N'-Tetrakis(2-hydroxypropyl)ethylenediamine) | 1 |
| 31 | MTPPA(M 5011) | 1 |
| 32 | GDC-0927 Racemate(SRN-927 Racemate) | 1 |
| 33 | 5(6)-FAM SE(5(6)-Carboxyfluorescein N-hydroxysuccinimide ester) | 1 |
| 34 | β-Casomorphin,bovine(β-Casomorphin-7(bovine)) | 1 |
| 35 | Hexadimethrine bromide(1,5-Dimethyl-1,5-diazaundecamethylene polymethobromide) | 1 |
| 36 | Guanosine-2'(3')-monophosphate disodium salt | 1 |
| 37 | 11β-Prostaglandin E1 | 1 |
| 38 | Tridocosahexaenoin | 1 |
| 39 | 11094-59-0 | 1 |
| 40 | (±)11-HEDE | 1 |
| 41 | 5-Fluoropentylindole | 1 |
| 42 | 1859218-30-6 | 1 |
| 43 | Linoleic Acid Alkyne | 1 |
| 44 | 1219038-31-9 | 1 |
| 45 | 13,14-dihydro-15-keto Prostaglandin F2α | 1 |
| 46 | Prostaglandin F2βMaxSpec? Standard | 1 |
| 47 | 3-Acetylmorphine | 1 |
| 48 | 5140-28-3 | 1 |
| 49 | 2-methyl-3-Pyrimidin-2-yl-Propionic Acid | 1 |
| 50 | 13,14-dihydro-15-keto Prostaglandin A2 MaxSpec? Standard | 1 |
| 51 | 1,3-Diarachidoyl-rac-glycerol | 1 |
| 52 | 59925-28-9 | 1 |
| 53 | 1-Benzyl-3-methylpiperazine | 1 |
| 54 | 5-APDI(hydrochloride) | 1 |
| 55 | 152623-95-5 | 1 |
| 56 | 6β-Hydrocodol | 1 |
| 57 | 795-38-0 | 1 |
| 58 | AB-FUBICA | 1 |
| 59 | 1801338-22-6 | 1 |
| 60 | AM694 N-pentanoic acid metabolite | 1 |
| 61 | 1432900-96-3 | 1 |
| 62 | CAY10510 | 1 |
| 63 | 291303-34-9 | 1 |
| 64 | Eicosapentaenoic Acid(sodium salt) | 1 |
| 65 | EOS(d18:1/30:0/18:2) | 1 |
| 66 | 97040-38-5 | 1 |
| 67 | Quizalofop-p-ethyl((R)-Quizalofop ethyl) | 1 |
| 68 | 4-Methylumbelliferyl phosphate(4-MUP) | 1 |
| 69 | Docosahexaenoic Acid methyl ester(all cis-DHA methyl ester) | 1 |
| 70 | Ipenoxazone(MLV-6976) | 1 |
| 71 | Decoyinine(Angustmycin A) | 1 |
| 72 | Citenamide(AY-15613) | 1 |
| 73 | (±)-Medicarpin | 1 |
| 74 | Erythropterin | 1 |
| 75 | 7449-03-8 | 1 |
| 76 | Prednisolone farnesylate | 1 |
| 77 | β-Amyloid(1-42),rat | 1 |
| 78 | Bialaphos(sodium salt) | 1 |
| 79 | (±)-Lauroylcarnitine chloride | 1 |
| 80 | 7023-03-2 | 1 |
| 81 | beta-Nicotinamide mononucleotide | 1 |
| 82 | 3,4-Dimethoxyphenethylamine(hydrochloride) | 1 |
| 83 | 635-85-8 | 1 |
| 84 | ent-Prostaglandin F2α | 1 |
| 85 | 54483-31-7 | 1 |
| 86 | Naltrexone-d3 | 1 |
| 87 | 1261080-26-5 | 1 |
| 88 | (E)-8-Methyl-6-nonenoic Acid | 1 |
| 89 | 59320-77-3 | 1 |
| 90 | 1-Stearoyl-3-Linoleoyl-rac-glycerol | 1 |
| 91 | 126301-96-0 | 1 |
| 92 | (±)11(12)-EpETE | 1 |
| 93 | 2,3-dinor-8-iso Prostaglandin F2α | 1 |
| 94 | 221664-05-7 | 1 |
| 95 | RCS-4 N-(5-carboxypentyl)metabolite | 1 |
| 96 | 1427521-39-8 | 1 |
| 97 | Benzoylpiperazine | 1 |
| 98 | 13754-38-6 | 1 |
| 99 | NAMIE | 1 |
| 100 | 1638677-49-2 | 1 |
m.cnreagent.com